Abstract:Importance Understanding the effect of antenatal magnesium sulfate (MgSO 4 ) treatment on functional connectivity will help elucidate the mechanism by which it reduces the risk of cerebral palsy and death. Objective To determine whether MgSO 4 administered to women at risk of imminent preterm birth at a gestational age between 30 and 34 weeks is associated with increased functional connectivity and measures of functional segregation and integration in infants at term-equivalent age, possibly reflecting a protective mechanism of MgSO 4 . Design, Setting, and Participants This cohort study was nested within a randomized placebo-controlled trial performed across 24 tertiary maternity hospitals. Participants included infants born to women at risk of imminent preterm birth at a gestational age between 30 and 34 weeks who participated in the MAGENTA (Magnesium Sulphate at 30 to 34 Weeks' Gestational Age) trial and underwent magnetic resonance imaging (MRI) at term-equivalent age. Ineligibility criteria included illness precluding MRI, congenital or genetic disorders likely to affect brain structure, and living more than 1 hour from the MRI center. One hundred and fourteen of 159 eligible infants were excluded due to incomplete or motion-corrupted MRI. Recruitment occurred between October 22, 2014, and October 25, 2017. Participants were followed up to 2 years of age. Analysis was performed from February 1, 2021, to February 27, 2024. Observers were blind to patient groupings during data collection and processing. Exposures Women received 4 g of MgSO 4 or isotonic sodium chloride solution given intravenously over 30 minutes. Main Outcomes and Measures Prior to data collection, it was hypothesized that infants who were exposed to MgSO 4 would show enhanced functional connectivity compared with infants who were not exposed. Results A total of 45 infants were included in the analysis: 24 receiving MgSO 4 treatment and 21 receiving placebo; 23 (51.1%) were female and 22 (48.9%) were male; and the median gestational age at scan was 40.0 (IQR, 39.1-41.1) weeks. Treatment with MgSO 4 was associated with greater voxelwise functional connectivity in the temporal and occipital lobes and deep gray matter structures and with significantly greater clustering coefficients (Hedge g , 0.47 [95% CI, −0.13 to 1.07]), transitivity (Hedge g , 0.51 [95% CI, −0.10 to 1.11]), local efficiency (Hedge g , 0.40 [95% CI, −0.20 to 0.99]), and global efficiency (Hedge g , 0.31 [95% CI, −0.29 to 0.90]), representing enhanced functional segregation and integration. Conclusions and Relevance In this cohort study, infants exposed to MgSO 4 had greater voxelwise functional connectivity and functional segregation, consistent with increased brain maturation. Enhanced functional connectivity is a possible mechanism by which MgSO 4 protects against cerebral palsy and death.

Effects of magnesium oxide nanoparticles on memory impairment induced by postpartum depression model

Effects of Magnesium Sulfate on Neuron Apoptosis and Expression of Caspase-3, Bax and Bcl-2 after Cerebral Ischemia-Reperfusion Injury

Effects of zinc and magnesium supplements on postpartum depression and anxiety: A randomized controlled clinical trial

The effect of magnesium sulfate on memory and anxiety-like behavior in a rat model: an investigation of its neuronal molecular mechanisms

Neurobehavioral and biochemical effects of magnesium chloride (MgCl2), magnesium sulphate (MgSO4) and magnesium-L-threonate (MgT) supplementation in rats: A dose dependent comparative study

The Causal Role of Magnesium Deficiency in the Neuroinflammation, Pain Hypersensitivity and Memory/Emotional Deficits in Ovariectomized and Aged Female Mice

Association of Postpartum Depression with Maternal Serum Magnesium Levels, Infant Growth, and Neurodevelopmental Indices

Magnesium Oxide in Nanodimension: Model for MRI and Multimodal Therapy

Effect of sub-acute exposure of metal-organic framework-199 on cognitive function and oxidative stress level of brain tissue in rat

Time- and sex-dependent efficacy of magnesium sulfate to prevent behavioral impairments and cerebral damage in a mouse model of cerebral palsy

Randomized study of the effects of vitamin D and/or magnesium supplementation on mood, serum levels of BDNF, inflammation, and SIRT1 in obese women with mild to moderate depressive symptoms

Fetal Neuroprotective Mechanism of Maternal Magnesium Sulfate: Proteomic Analysis

Effects of elevation of brain magnesium on fear conditioning, fear extinction, and synaptic plasticity in the infralimbic prefrontal cortex and lateral amygdala

Temporal and dosage impact of magnesium oxide nanoparticles on grass carp: unveiling oxidative stress, DNA damage, and antioxidant suppression

Magnesium Sulfate Prevents Neurochemical and Long-Term Behavioral Consequences of Neonatal Excitotoxic Lesions: Comparison Between Male and Female Mice

Effect of titanium dioxide nanoparticles administered during pregnancy on depression-like behavior in forced swimming and tail suspension tests in offspring mice

Chronic Oral Administration of Magnesium-L-Threonate Prevents Oxaliplatin-Induced Memory and Emotional Deficits by Normalization of TNF-α/NF-κB Signaling in Rats

Effects of long-term magnesium L-threonate supplementation on neuroinflammation, demyelination and blood-brain barrier integrity in mice with neuromyelitis optica spectrum disorder

Short-Term Effect of MgSO4 on the Expression of NRG-ErbB, Dopamine, GABA, and Glutamate Systems in the Fetal Rat Brain

The Neuroprotective and Anxiolytic Effects of Magnesium Sulfate on Retinal Dopaminergic Neurons in 6-OHDA-Induced Parkinsonian Rats: A Pilot Study

Prenatal MgSO 4 and Functional Connectivity in Offspring at Term-Equivalent Age